Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Prospective, Double-Blinded, Randomized Controlled Trial of the Micronized dHACM Injection As Compared To Saline Placebo Injection In The Treatment Of Plantar Fasciitis

NCT03414268 is registered in ClinicalTrials.gov with MiMedx Group, Inc. as lead sponsor.

NCT NCT03414268
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03414268 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Prospective, Double-Blinded, Randomized Controlled Trial of the Micronized dHACM Injection As Compared To Saline Placebo Injection In The Treatment Of Plantar Fasciitis
Lead sponsor
MiMedx Group, Inc.
Phase
Phase 3
Overall status
Completed
Start date
January 8, 2018
Completion date
March 17, 2021
Enrollment
208 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

fasciitis, plantar